Patents
Literature
2 results about "Drug elution" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Drug-eluting stents (DES) are a standard metallic coronary stent with a polymer coating and an antiproliferative drug, which allows drug elution into the coronary wall for weeks to months after stent implantation.
Customizable Inflatable Bolster Apparatus
A customizable inflatable bolster apparatus (100) may include a first leaf (102), a second leaf (104), or a balloon (108) disposed between the first leaf (102) and the second leaf (104) or on a single leaf. The balloon (108) may include an inflation port (110) and one or more tethers (112)(1)-(n)). The one or more tethers (112)(1)-(n)) may be disposed within the balloon (108) or around an external surface of the balloon (108). In response to the balloon (108) inflating, the one or more tethers ((112)(1)-(n)) may shape the balloon (108) into a desired shape. The apparatus (100) may apply a pressure to the tissue of patient and immobilize the tissue. The apparatus (100) may be applied to a skin graft, a patient's tissue, or a mucosa or fascia of the patient. The apparatus (100) may elute a substance, such as a pharmaceutical, into the tissue of the patient.
Owner:VANDERBILT UNIV
Schlemm's canal drug eluting device and method
A method of delivering a pharmaceutical composition to Schlemm's canal of an eye is disclosed. The method may comprise inserting a drug delivery device in conjunction with a microstent into Schlemm's canal. The drug delivery device may comprise a bioerodable polymer and a pharmaceutical composition, and the drug delivery device may be configured to erode over time and to elute the pharmaceutical composition into aqueous humor within Schlemm's canal as it erodes.
Owner:ALCON INC